DCN is a clinical department that seeks to integrate high class clinical care with research. We straddle the University of Edinburgh and teaching hospitals (Royal Infirmary of Edinburgh and Western General Hospital) campus and combine patient driven research, large-scale international trials and laboratory research around five main areas; Stroke, Prion disease, Brain Imaging, Neuro-oncology and Regenerative Neurology (focussed on multiple sclerosis and motor neurone disease).
DCN is a division within the Centre for Clinical Brain Sciences.
 |
 |
 |
 |
||
 |
||
Edinburgh stroke paper shortlisted for award
Prof Peter Sandercock and colleagues have been short-listed for the Open Data Award from BioMed Central for their article 'The International Stroke Trial Database'. This award seeks to recognize researchers who have published in BioMed Central journals and have demonstrated leadership in the sharing, standardization, publication, or re-use of biomedical research data. The Award winner will be announced at a ceremony on 17th May at the Emirates Stadium in London.
Peters video can be viewed here: http://dcnapp1.dcn.ed.ac.uk/neurotube/player/player.asp?vidID=bji81231
Neuroscience Day 2012
Neuroscience Day 2012 was attended by over 300 researchers this year and there was a terrific series of talks. Congratulations to Hanna Vesterinen who received special commendation for her poster: Prevalence and impact of publication bias in pre-clinical studies of multiple sclerosis in the Pfizer-supported poster competition.
€11m for stroke research in hypothermia
Researchers in the Stroke Research Group are part of a European Consortium which has been awarded €11m for a clinical trial of therapeutic cooling for stroke. Joanna Wardlaw leads the imaging work package, and Malcolm Macleod leads the data management work package and is scientific liaison officer for study. Further details at www.eurohyp1.eu.
£1.34 million to conduct RESTART
The British Heart Foundation has awarded a five year Special Project Grant worth £1.34 million to conduct the RESTART (REstart or STop Antiplatelets Randomised Trial) in the UK. The application was led by Dr Rustam Al-Shahi Salman (MRC senior clinical fellow), and also includes Prof Martin Dennis (Prof of Stroke Medicine), Prof Gordon Murray (Prof of Medical Statistics), Prof David Newby BHF Prof of Cardiology), Prof Peter Sandercock (Prof of Clinical Neurology), Dr Cathie Sudlow (Reader in Clinical Neurology), Dr Phil White (Reader in Neuroradiology), and Dr Will Whiteley (MRC clinician scientist).
At least one quarter of adults with a stroke due to intracerebral haemorrhage are on drugs like aspirin at the time of the bleed because they had previously suffered vaso-occlusive disease. For 720 people like this who survive the brain haemorrhage, RESTART will test whether more brain haemorrhages occur after restarting drugs like aspirin than after stopping them, and it will investigate whether brain microbleeds on brain MRI are important effect modifiers. If restarting antiplatelet drugs does not raise the risk of further brain haemorrhage, continuing them could allow survivors to continue to benefit from them.
Stroke patients could get to hospital quicker thanks to a new smartphone App
The FAST test app - the first of its kind - has been devised by Graeme Heron and Dr. William Whiteley in the Division of Clinical Neurosciences University of Edinburgh to provide people with a simple test to spot stroke.
 |
 |
 |
| Scan with QR code reader |